PHYTOTHERAPY IN SEVERE ACUTE RESPIRATORYSYNDROME CORONAVIRUS 2

THE EFFECTIVENESS OF PHYTOTHERAPY IN THE TREATMENT OF SEVERE ACUTE RESPIRATORYSYNDROME CORONAVIRUS 2

Sponsors

Lead Sponsor: Hôpital Universitaire Sahloul

Source Hôpital Universitaire Sahloul
Brief Summary

Quercetin is one of the flavonoids. These are pigments - there are over 4000 of them! - which give their colors to flowers, fruits and vegetables. These compounds naturally present in plants have many effects on the body, the main one being to strengthen the walls of capillaries (the smallest blood vessels) and to reduce their permeability. Quercetin as well as rutin are recognized to be among the most active of the flavonoids. It is to quercetin that several medicinal plants, including ginkgo and St. John's Wort, owe part of their therapeutic effects. Often combined with vitamin C in supplements, it improves absorption by the body and delays its elimination. Quercetin is extracted from a variety of plant sources, including the onion peel and seeds and pods of Dimorphandra mollis, a tree in the legume family native to South America.

Overall Status Recruiting
Start Date 2021-01-04
Completion Date 2021-06-30
Primary Completion Date 2021-02-28
Phase Phase 1
Study Type Interventional
Primary Outcome
Measure Time Frame
efficiency 10 DAYS
Secondary Outcome
Measure Time Frame
Date of disappearance of symptoms present on admission 10 days after inclusion
adverse reaction 10 days after inclusion
Enrollment 80
Condition
Intervention

Intervention Type: Drug

Intervention Name: Quercetin

Description: Each patient included, after signing the consent, will have a treatment for ten days: one tablet times three per day 30 minutes before the meal.

Other Name: PLACEBO

Eligibility

Criteria:

Inclusion Criteria: - all patients attending the emergency department for influenza-like illness. - Being over 18 years old Exclusion Criteria: - Any patient requiring admission - Non-consenting patients

Gender:

All

Minimum Age:

18 Years

Maximum Age:

N/A

Healthy Volunteers:

No

Overall Official
Last Name Role Affiliation
Riadh Boukef, professor Principal Investigator CHU Sahloul, Sousse, Tunisia
Overall Contact

Last Name: Riadh Boukef, professor

Phone: 0021698676745

Email: [email protected]

Location
Facility: Status: Contact: Riadh Boukef RIADH BOUKEF, Professor 0021698676745 [email protected]
Location Countries

Tunisia

Verification Date

2021-04-01

Responsible Party

Type: Sponsor

Has Expanded Access No
Condition Browse
Number Of Arms 2
Arm Group

Label: Quercetix group

Type: Experimental

Label: Placebo Group

Type: Placebo Comparator

Acronym Quercetix
Patient Data Yes
Study Design Info

Allocation: Randomized

Intervention Model: Parallel Assignment

Primary Purpose: Treatment

Masking: Double (Participant, Care Provider)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact [email protected]. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Research News